Our results revealed for the first time that the upregulation of PLA1A in the serum of advanced metastatic melanoma tissues represent an excellent diagnostic marker in BRAF/NRAS-driven melanomagenesis. The gene discussed is BRAF; the disease is metastatic melanoma.